Vontobel Holding Ltd. Sells 81 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Vontobel Holding Ltd. cut its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 1.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,416 shares of the financial services provider’s stock after selling 81 shares during the period. Vontobel Holding Ltd.’s holdings in iShares Biotechnology ETF were worth $600,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in IBB. CWM LLC boosted its holdings in iShares Biotechnology ETF by 2.1% in the third quarter. CWM LLC now owns 8,927 shares of the financial services provider’s stock valued at $1,092,000 after acquiring an additional 183 shares during the last quarter. AE Wealth Management LLC boosted its holdings in iShares Biotechnology ETF by 17.8% in the third quarter. AE Wealth Management LLC now owns 22,893 shares of the financial services provider’s stock valued at $2,800,000 after acquiring an additional 3,467 shares during the last quarter. Geneos Wealth Management Inc. boosted its holdings in iShares Biotechnology ETF by 16.7% in the third quarter. Geneos Wealth Management Inc. now owns 644 shares of the financial services provider’s stock valued at $79,000 after acquiring an additional 92 shares during the last quarter. HB Wealth Management LLC acquired a new position in iShares Biotechnology ETF in the third quarter valued at approximately $219,000. Finally, Cedar Brook Financial Partners LLC lifted its stake in iShares Biotechnology ETF by 26.6% in the third quarter. Cedar Brook Financial Partners LLC now owns 3,492 shares of the financial services provider’s stock valued at $427,000 after buying an additional 733 shares during the period. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Price Performance

Shares of IBB opened at $126.11 on Tuesday. iShares Biotechnology ETF has a 52-week low of $111.83 and a 52-week high of $141.16. The business’s 50 day moving average price is $134.89 and its two-hundred day moving average price is $129.71.

iShares Biotechnology ETF Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were paid a $0.126 dividend. This represents a $0.50 annualized dividend and a yield of 0.40%. The ex-dividend date was Thursday, March 21st.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.